Shanghai, China

Guanghai Xu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.8

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Guanghai Xu: Innovator in Pharmaceutical Chemistry

Introduction

Guanghai Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of three patents to his name, Xu's work focuses on innovative solutions for treating diseases.

Latest Patents

Xu's latest patents include a heterocyclic compound as a CSF-1R inhibitor. This invention relates to a class of isoindolinone derivatives and their use in preparing a medicament for treating diseases associated with a novel colony stimulating factor 1 receptor (CSF-1R) inhibitor. Specifically, it involves a compound of formula (I) and its pharmaceutically acceptable salts or stereoisomers. Another notable patent is for a prostacyclin receptor agonist, which is represented by formula (I) or its isomers or pharmaceutically acceptable salts. This invention also pertains to its application in preparing a drug for treating diseases related to a PGI receptor.

Career Highlights

Throughout his career, Guanghai Xu has worked with several reputable companies, including Medshine Discovery Inc. and Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory. His experience in these organizations has allowed him to advance his research and contribute to the pharmaceutical industry significantly.

Collaborations

Xu has collaborated with notable colleagues in his field, including Wenyuan Qian and Chundao Yang. These partnerships have fostered innovation and have been instrumental in the development of his patented inventions.

Conclusion

Guanghai Xu is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…